The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis

被引:57
作者
Perng, Cheng-Hwang [1 ]
Chang, Yue-Cune [2 ]
Tzang, Ruu-Fen [3 ,4 ,5 ]
机构
[1] Aletheia Univ, Dept Stat & Actuarial Sci, New Taipei, Taiwan
[2] Tamkang Univ, Dept Math, New Taipei, Taiwan
[3] Mackay Mem Hosp, Dept Psychiat, 92,Sec 2,Zhong Shan N Rd, Taipei 104, Taiwan
[4] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan
[5] Mackay Med Coll, New Taipei, Taiwan
关键词
Dementia; Alzheimer disease; Vascular dementia; Cognitive impairment; Cognitive function; Meta-regression; RANDOMIZED CONTROLLED-TRIALS; MODERATE ALZHEIMERS-DISEASE; SENILE VASCULAR DEMENTIA; EFFICACY; IMPAIRMENT; THERAPY; PEOPLE; DONEPEZIL; SYMPTOMS; SAFETY;
D O I
10.1007/s00213-018-4867-y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
No cure is currently available for dementia; however, various treatments and interventions have been reported to be effective. The factors influencing the efficacy of dementia treatment have not been comprehensively evaluated. This study evaluated the factors influencing treatment effects on cognitive dysfunction in dementia by comparing the results obtained from a meta-analysis based on meta-regression. We searched for articles, clinical trials, and meta-analyses on the efficacy of pharmacotherapy or psychosocial treatment for dementia published between 2000 and 2016 in the MEDLINE/PubMed, Cochrane Library, SCOPUS, and Airiti Library databases. The 235 selected studies involved 44,854 patients with dementia (mainly vascular dementia, Alzheimer disease, and mild cognitive impairment). A preliminary random effects meta-analysis yielded a positive overall effect. The pooled standardized mean difference of the treatment effects on cognitive dysfunction was 0.439 (95% confidence interval 0.374, 0.504). The results of meta-regression showed that in young patients (beta = - 0.036, p value < 0.001) with vascular dementia (beta = 0.603, p value < 0.001), the efficacies of treatment 2 (symptomatic treatment for vascular dementia with piracetam, nimodipine, aniracetam, flunarizine, vinpocetine, hyperbaric oxygen, oxiracetam, or EGB761) and treatment 5 (treatment with other alternative therapies including acupuncture, premarin, statin, butylphthalide soft capsules, donepezil, huperzine A, and lithium treatment) were higher than those of other existing treatments for cognitive dysfunction (beta = 0.308 and 0.321, p values = 0.010 and < 0.001, respectively). The most effective intervention for dementia available is symptomatic treatment for vascular dementia. Antipsychotic treatment for dementia alleviates cognitive dysfunction less effectively than does symptomatic treatment. Alternative therapies are also effective at present. Further research on causes and very early diagnosis of Alzheimer disease is warranted.
引用
收藏
页码:1571 / 1580
页数:10
相关论文
共 42 条
[1]   Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials [J].
Abushouk, Abdelrahman Ibrahim ;
Elmaraezy, Ahmed ;
Aglan, Amro ;
Salama, Reham ;
Fouda, Samar ;
Fouda, Rana ;
AlSafadi, Ammar M. .
BMC NEUROLOGY, 2017, 17
[2]  
Aigbogun Myrlene Sanon, 2017, Alzheimers Dement (Amst), V8, P51, DOI 10.1016/j.dadm.2017.04.001
[3]  
[Anonymous], ECAM
[4]  
[Anonymous], J CHANGCHUN U CHINES
[5]  
Cao L, 2015, MED J CHINESE PEOPLE, V27, P41
[6]   The efficacy of music therapy for people with dementia: A meta-analysis of randomised controlled trials [J].
Chang, Yu-Shiun ;
Chu, Hsin ;
Yang, Chyn-Yng ;
Tsai, Jui-Chen ;
Chung, Min-Huey ;
Liao, Yuan-Mei ;
Chi, Mei-ju ;
Liu, Megan F. ;
Chou, Kuei-Ru .
JOURNAL OF CLINICAL NURSING, 2015, 24 (23-24) :3425-3440
[7]   Clinical Research on Comprehensive Treatment of Senile Vascular Dementia [J].
Chen Li-ping ;
Wang Fa-wei ;
Zuo Fang ;
Jia Jian-jun ;
Jiao Wei-guo .
JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2011, 31 (03) :178-181
[8]  
Cheng Q-S, 2014, PRACT J CARDIAC CERE, V22, P18
[9]   Worldwide trends in the prevalence of dementia [J].
Cova, Ilaria ;
Markova, Anna ;
Campini, Isabella ;
Grande, Giulia ;
Mariani, Claudio ;
Pomati, Simone .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 379 :259-260
[10]   Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease [J].
Doody, Rachelle S. ;
Thomas, Ronald G. ;
Farlow, Martin ;
Iwatsubo, Takeshi ;
Vellas, Bruno ;
Joffe, Steven ;
Kieburtz, Karl ;
Raman, Rema ;
Sun, Xiaoying ;
Aisen, Paul S. ;
Siemers, Eric ;
Liu-Seifert, Hong ;
Mohs, Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (04) :311-321